Invention Grant
- Patent Title: IC31 nanoparticles
- Patent Title (中): IC31纳米粒子
-
Application No.: US14258119Application Date: 2014-04-22
-
Publication No.: US09248180B2Publication Date: 2016-02-02
- Inventor: Benjamin Wizel , Karin Riedl , Karen Lingnau , Ursula Schlosser , Jürgen Wruss , Robert Schlegl , Michael Weber , Christoph Reinisch , Ljubomir Paucz , Christoph Klade , Jee Loon Look , Christian Ruiz , Robert Seid
- Applicant: Valneva Austria GmbH
- Applicant Address: AT Vienna
- Assignee: Valneva Austria GmbH
- Current Assignee: Valneva Austria GmbH
- Current Assignee Address: AT Vienna
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K9/51
- IPC: A61K9/51 ; A61K9/14 ; A61K39/40 ; A61K39/42 ; A61K39/39 ; A61K9/00 ; A61K9/08 ; A61K9/10 ; A61K38/00 ; A61K39/00 ; A61K39/09 ; A61K39/12 ; A61K39/145 ; A61K48/00 ; A61K39/118 ; C12N7/00
Abstract:
The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 μm.
Public/Granted literature
- US20150216967A1 IC31 NANOPARTICLES Public/Granted day:2015-08-06
Information query
